Additional shares required to issue upon achieving development milestone.

No definition available.

Name:	eras_AdditionalSharesRequiredToIssueUponAchievingDevelopmentMilestone
Namespace Prefix:	eras_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Future development and regulatory milestone cash payments maximum.

+ References

No definition available.

+ Details

Name:	eras_FutureDevelopmentAndRegulatoryMilestoneCashPaymentsMaximum
Namespace Prefix:	eras_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

In process research and development expense.

+ References

No definition available.

+ Details

Name:	eras_InProcessResearchAndDevelopmentExpense
Namespace Prefix:	eras_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Milestones accrued.

+ References

No definition available.

+ Details

Name:	eras_MilestonesAccrued
Namespace Prefix:	eras_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Upfront payment made.

+ References

No definition available.

+ Details

Name:	eras_UpfrontPaymentMade
Namespace Prefix:	eras_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480123/805-50-15-3

+ Details

Name:	us-gaap_AssetAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479581/805-30-50-1

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of shares issued during the period as a result of the conversion of convertible securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-SubTopic 10
-Topic 505
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-3

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-30)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=eras_AsanaMergerAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=eras_SeriesB2ConvertiblePreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=eras_EmergeLifeSciencesPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Asset Acquisitions - Additional Information (Details) - USD ($)	1 Months Ended		3 Months Ended
	Mar. 31, 2021	Nov. 30, 2020	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Asana Merger Agreement
Asset Acquisition [Line Items]
Upfront payment made		$ 20,000,000
Future development and regulatory milestone cash payments maximum		$ 90,000,000
Additional shares required to issue upon achieving development milestone		3,888,889
In-process research and development			$ 0	$ 0
Milestones accrued			0		$ 0
Asana Merger Agreement \| Series B-2 Convertible Preferred Stock
Asset Acquisition [Line Items]
Shares issued		4,000,000
Value per share		$ 7.5
Total fair value of equity		$ 30,000,000
Asana Merger Agreement \| Series B-2 Convertible Preferred Stock \| Common Stock \| IPO
Asset Acquisition [Line Items]
Convertible preferred stock converted into shares of common stock		3,333,333
ELS Purchase Agreement
Asset Acquisition [Line Items]
Upfront payment made	$ 2,000,000
In-process research and development			$ 0	$ 0
ELS Purchase Agreement \| Common Stock
Asset Acquisition [Line Items]
Shares issued	500,000
Value per share	$ 3.36
Total fair value of equity	$ 1,700,000